Literature DB >> 7809466

Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity.

N Rastogi1, W W Barrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7809466     DOI： 10.1016/0923-2508(94)90012-4

Source DB:  PubMed          Journal:  Res Microbiol        ISSN： 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  5 in total

1.  Comparative evaluation of PCR and commercial DNA probes for detection and identification to species level of Mycobacterium avium and Mycobacterium intracellulare.

Authors:  A Devallois; M Picardeau; K S Goh; C Sola; V Vincent; N Rastogi
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

2.  Molecular characterization of Mycobacterium avium complex isolates giving discordant results in AccuProbe tests by PCR-restriction enzyme analysis, 16S rRNA gene sequencing, and DT1-DT6 PCR.

Authors:  A Devallois; M Picardeau; C N Paramasivan; V Vincent; N Rastogi
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.

Authors:  N Rastogi; K S Goh; A Bryskier; A Devallois
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex.

Authors:  N Rastogi; R M Bauriaud; A Bourgoin; B Carbonnelle; C Chippaux; M J Gevaudan; K S Goh; D Moinard; P Roos
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

5.  Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages.

Authors:  N Rastogi; V Labrousse; A Bryskier
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.